First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC ...

An Australian biotech firm says it has successfully used precision fermentation to reproduce the most vital proteins in human ...

Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, today announces the appointment of Francis Van Parys as Chief Executive ...

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

As global temperatures rise, Cold Spring Harbor Laboratory (CSHL) scientists work to grow stronger, more resilient crops. Yet ...

On a video call in early September, Sarah Tabrizi first saw the data that she and other researchers studying Huntington’s ...

To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...

Recursion Pharma , which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths in the colon in patients with a rare ...

Paranovus Entertainment (NASDAQ: PAVS) Goes Parabolic on Interim Results ...

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

It's a watershed moment for in vitro fertilization (IVF), which can be difficult and expensive. Doctors are hopeful AI can ...